📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy. (2019)

First Author: Fervenza FC

Attributed to: Understanding the autoimmune mechanism in idiopathic membranous nephropathy (IMN) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1056/nejmoa1814427

PubMed Identifier: 31269364

Publication URI: http://europepmc.org/abstract/MED/31269364

Type: Journal Article/Review

Volume: 381

Parent Publication: The New England journal of medicine

Issue: 1

ISSN: 0028-4793